Xtandi 40 MG capsule 120S
Ended Awarded
- Contract number
- SPE2DB25FX8A4
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,245
Award facts
- Contract value 100% obligated
- $17,245.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $17,245.40 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for 120 capsules of Xtandi 40 mg on September 25, 2025, with an ultimate completion date of September 26, 2025. This award carries no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected as the prime contractor. Xtandi is an oncology treatment medication, consistent with the company's established portfolio of specialty pharmaceutical products supplied to federal healthcare facilities.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, valued at $499,999,999 and valid through November 2026. This umbrella contract enables the agency to procure a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to support Department of Defense healthcare operations worldwide. DMS Pharmaceutical Group has demonstrated consistent success in securing federal pharmaceutical contracts through its woman-owned small business status and established capabilities as a critical supplier within the federal pharmaceutical supply chain serving military health facilities.
Quick answers
Who was awarded contract SPE2DB25FX8A4?
SPE2DB25FX8A4 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 25, 2025.
How much is contract SPE2DB25FX8A4 worth?
The government has obligated $17,245 on SPE2DB25FX8A4.
Is contract SPE2DB25FX8A4 an order under another contract?
Yes. SPE2DB25FX8A4 is a delivery order under SPE2DB20D9354, an indefinite delivery contract.
Was contract SPE2DB25FX8A4 competed?
The extent of competition for SPE2DB25FX8A4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award